Pharmbio Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Pharmbio Korea Co Ltd (Pharmbio) is a pharmaceutical company that manufactures and markets original prescribing drugs and OTC drugs for various therapeutic segments. The company offers products in therapeutic areas of urology, gastroenterology, pediatrics, pain control, obstetrics and gynaecology products, among others. Its products include urocitra, rowatinex, rowachol and hepadial. Pharmbios rowatinex promotes diuresis and relaxes urinary tract spasm for assisting the passage of stones. Its rowachol is indicated for the treatment of hepato-biliary disorders including the dissolution of gallstones. The company offers its products in the dosage forms of solutions, powders and tablets. It markets its products through its network of distributors. Pharmbio is headquartered in Seoul, South Korea.

Pharmbio Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Pharmbio Korea Enters into Licensing Agreement with Trevena 10
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Pharmbio Korea Enters into Licensing Agreement with Faron Pharma 12
Pharmbio Korea Co Ltd - Key Competitors 13
Pharmbio Korea Co Ltd - Key Employees 14
Pharmbio Korea Co Ltd - Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List Of Tables


Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pharmbio Korea Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Pharmbio Korea Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Pharmbio Korea Enters into Licensing Agreement with Trevena 10
Pharmbio Korea Enters into Licensing Agreement with Shionogi 11
Pharmbio Korea Enters into Licensing Agreement with Faron Pharma 12
Pharmbio Korea Co Ltd, Key Competitors 13
Pharmbio Korea Co Ltd, Key Employees 14

List Of Figures


Xinjiang Goldwind Science & Technology Co Ltd, Performance Chart (2013 - 2017) 31
Xinjiang Goldwind Science & Technology Co Ltd, Ratio Charts 33
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals By Year, 2012 to YTD 2018 34
Xinjiang Goldwind Science & Technology Co Ltd, Power, Deals by Type, 2012 to YTD 2018 35

Pharmbio Korea Co Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Pharmbio Korea Co Ltd (Pharmbio) is a pharmaceutical company that manufactures and markets original prescribing drugs and OTC drugs for various therapeutic segments. The company offers products in therapeutic areas

USD 250 View Report

South Korea Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

This comprehensive report from LeadingMarketResearch.com contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next

USD 2500 View Report

Asia Pacific Korea Cosmetic Ingredients Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Korea Cosmetic Ingredients market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available